雌激素及其受体在绝经前后女性脂肪组织葡萄糖代谢中的作用
研究比较绝经前与绝经后女性皮下和内脏脂肪组织中ESR1和ESR2的表达,并检测雌二醇对脂肪细胞葡萄糖摄取的影响。结果显示绝经后女性ESR2表达降低、ESR1:ESR2比值降低;在绝经晚期而非绝经前或绝经早期女性中,雌二醇减少葡萄糖摄取和GLUT4蛋白并增加ESR2表达。ESR1和ESR2多态性与体重、体脂分布及血脂指标相关。
要点
- 绝经后女性脂肪组织ESR2表达降低,ESR1:ESR2比值降低。
- 绝经前女性内脏脂肪ESR1表达高于皮下脂肪。
- 绝经晚期女性雌二醇减少脂肪细胞葡萄糖摄取和GLUT4蛋白。
核心结论
- 雌二醇抑制绝经晚期女性脂肪细胞葡萄糖利用,绝经后时间变化可能由较低的ESR1:ESR2比值解释,对绝经后雌激素治疗时机有临床意义。
研究设计与样本
- 获取绝经前(19-51岁)和绝经后(46-75岁)女性皮下脂肪组织和内脏脂肪组织,检测ESR1和ESR2基因表达;皮下脂肪组织与雌二醇共孵育后检测葡萄糖摄取和雌激素受体水平;在公共数据库中分析ESR1和ESR2多态性与代谢特征的关联。
主要发现
- 绝经前女性ESR2表达低于绝经后女性,对应绝经后女性ESR1:ESR2基因表达比值较低。
- 绝经前女性内脏脂肪ESR1表达高于皮下脂肪;绝经前和绝经后女性内脏脂肪ESR2表达均低于皮下脂肪。
- 在绝经晚期而非绝经前或绝经早期女性中,雌二醇降低葡萄糖摄取和GLUT4蛋白并增加ESR2表达。
- ESR1多态性与体重、体脂分布和总胆固醇相关;ESR2多态性与总胆固醇、甘油三酯水平和体脂百分比相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Reduced estrogen levels in postmenopausal women predispose them to metabolic side effects, including insulin resistance and type 2 diabetes; however, the cellular mechanisms are not well understood. OBJECTIVE: This work aimed to study the expression of estrogen receptors in adipose tissue from pre- and postmenopausal women and the effects of estradiol (E2) on glucose uptake of adipocytes. METHODS: Subcutaneous (SAT) and visceral adipose tissue (VAT) obtained from pre- and postmenopausal women (19-51 and 46-75 years old, respectively) were used to measure gene expression of ESR1 and ESR2. SAT tissue was incubated with E2, and glucose uptake and estrogen receptor levels were measured. Polymorphisms in ESR1 and ESR2 were addressed in public databases to identify single nucleotide polymorphisms associated with metabolic traits. RESULTS: ESR2 expression was lower in pre- vs postmenopausal women, corresponding to lower ESR1:ESR2 gene expression ratio in postmenopausal women. In premenopausal women, the expression of ESR1 was higher in VAT than in SAT. In both pre- and postmenopausal women, ESR2 expression was lower in VAT than in SAT. In late, but not pre- or early postmenopausal women, E2 reduced glucose uptake and GLUT4 protein and increased expression of ESR2. ESR1 polymorphisms were associated with weight, body fat distribution, and total cholesterol, and ESR2 polymorphisms were associated with total cholesterol and triglyceride levels and with body fat percentage. CONCLUSION: E2 inhibits glucose utilization in human adipocytes in late postmenopausal women. Changes in glucose utilization over time since menopause may be explained by a lower ESR1:ESR2 ratio. This can have clinical implications on the timing of estrogen treatment in postmenopausal women.
引用
- Ahmed F, Kamble PG, Hetty S, et al. Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women. J Clin Endocrinol Metab. 2022. PMID: 35084504. doi:10.1210/clinem/dgac042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。